BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 25966845)

  • 1. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
    J Hematol Oncol; 2015 May; 8():50. PubMed ID: 25966845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
    J Hematol Oncol; 2015 May; 8(1):57. PubMed ID: 27391317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
    Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression.
    Nie FQ; Sun M; Yang JS; Xie M; Xu TP; Xia R; Liu YW; Liu XH; Zhang EB; Lu KH; Shu YQ
    Mol Cancer Ther; 2015 Jan; 14(1):268-77. PubMed ID: 25504755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.
    Zhang EB; Kong R; Yin DD; You LH; Sun M; Han L; Xu TP; Xia R; Yang JS; De W; Chen Jf
    Oncotarget; 2014 Apr; 5(8):2276-92. PubMed ID: 24810364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
    Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
    Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
    Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
    J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12.
    Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
    J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
    Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.
    Nie F; Yu X; Huang M; Wang Y; Xie M; Ma H; Wang Z; De W; Sun M
    Oncotarget; 2017 Jun; 8(24):38227-38238. PubMed ID: 27246976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
    Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
    Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.